H
Hitoshi Matsuo
Researcher at Wakayama Medical University
Publications - 22
Citations - 836
Hitoshi Matsuo is an academic researcher from Wakayama Medical University. The author has contributed to research in topics: Fractional flow reserve & Coronary artery disease. The author has an hindex of 11, co-authored 22 publications receiving 491 citations.
Papers
More filters
Journal ArticleDOI
Diagnostic Performance of In‐Procedure Angiography‐Derived Quantitative Flow Reserve Compared to Pressure‐Derived Fractional Flow Reserve: The FAVOR II Europe‐Japan Study
Jelmer Westra,Birgitte Krogsgaard Andersen,Gianluca Campo,Hitoshi Matsuo,Lukasz Koltowski,Ashkan Eftekhari,Tommy Liu,Luigi Di Serafino,Domenico Di Girolamo,Javier Escaned,Holger Nef,Christoph Naber,Marco Barbierato,Shengxian Tu,Omeed Neghabat,Morten Madsen,Matteo Tebaldi,Toru Tanigaki,Janusz Kochman,Samer Somi,Giovanni Esposito,Giuseppe Mercone,Hernán Mejía-Rentería,Federico Ronco,Hans Erik Bøtker,William Wijns,Evald Høj Christiansen,Niels Ramsing Holm +27 more
TL;DR: Online computation of QFR in the catheterization laboratory is clinically feasible and is superior to angiographic assessment for evaluation of intermediary coronary artery stenosis using FFR as a reference standard.
Journal ArticleDOI
Real-world clinical utility and impact on clinical decision-making of coronary computed tomography angiography-derived fractional flow reserve: lessons from the ADVANCE Registry.
Timothy A. Fairbairn,Koen Nieman,Takashi Akasaka,Bjarne L. Nørgaard,Daniel S. Berman,Gilbert L. Raff,Lynne M. Hurwitz-Koweek,Gianluca Pontone,Tomohiro Kawasaki,Niels Peter Rønnow Sand,Jesper M. Jensen,Tetsuya Amano,Michael Poon,Kristian A. Øvrehus,Jeroen Sonck,Mark G. Rabbat,Sarah Mullen,Bernard De Bruyne,Campbell Rogers,Hitoshi Matsuo,Jeroen J. Bax,Jonathon Leipsic,Manesh R. Patel +22 more
TL;DR: In a large international multicentre population, FFRCT modified treatment recommendation in two-thirds of subjects as compared to CCTA alone, was associated with less negative ICA, predicted revascularization, and identified subjects at low risk of adverse events through 90 days.
Journal ArticleDOI
Coronary CT Angiography-derived Fractional Flow Reserve Testing in Patients with Stable Coronary Artery Disease: Recommendations on Interpretation and Reporting
Bjarne L. Nørgaard,Timothy A. Fairbairn,Robert D. Safian,Mark G. Rabbat,Brian Ko,Jesper M. Jensen,Koen Nieman,Kavitha Chinnaiyan,Niels Peter Rønnow Sand,Hitoshi Matsuo,Jonathon Leipsic,Gilbert L. Raff +11 more
TL;DR: Because F FRCT analysis provides a plethora of information regarding pressure and flow across the entire coronary tree, standardized criteria on interpretation and reporting of the FFRCT analysis result are of crucial importance both in context of the clinical adoption and in future research.
Journal ArticleDOI
Clinical implications of three-vessel fractional flow reserve measurement in patients with coronary artery disease.
Joo Myung Lee,Bon Kwon Koo,Bon Kwon Koo,Eun-Seok Shin,Chang-Wook Nam,Joon Hyung Doh,Doyeon Hwang,Jonghanne Park,Kyung Jin Kim,Jinlong Zhang,Xinyang Hu,Jian-an Wang,Chul Ahn,Fei Ye,Shao-Liang Chen,Junqing Yang,Jiyan Chen,Nobuhiro Tanaka,Hiroyoshi Yokoi,Hitoshi Matsuo,Hiroaki Takashima,Yasutsugu Shiono,Takashi Akasaka +22 more
TL;DR: Two-vessel FFR might be used as a prognostic indicator in patients with coronary artery disease and patients with high total physiologic atherosclerotic burden assessed by 3V-FFR showed higher risk of 2-year clinical events than those with low total physiotic burden.
Journal ArticleDOI
Rationale, design and goals of the HeartFlow assessing diagnostic value of non-invasive FFRCT in Coronary Care (ADVANCE) registry.
Kavitha Chinnaiyan,Takashi Akasaka,Tetsuya Amano,Jeroen J. Bax,Philipp Blanke,Bernard De Bruyne,Tomohiro Kawasaki,Jonathon Leipsic,Hitoshi Matsuo,Yoshihiro Morino,Koen Nieman,Bjarne L. Nørgaard,Manesh R. Patel,Gianluca Pontone,Mark G. Rabbat,Campbell Rogers,Neils Peter Sand,Gilbert L. Raff +17 more
TL;DR: The ADVANCE registry is designed to assess the real-world impact of FFRCT on the clinical management of stable CAD when used along with coronary CTA.